Department of Orthopaedics University of North Carolina at Chapel Hill — Chapel Hill, North Carolina

Department of Orthopaedics University of North Carolina at Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Department of Orthopaedics University of North Carolina at Chapel Hill has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Osteoarthritis, Avascular Necrosis of Bone of Hip, Post-traumatic; Arthrosis.

Sponsors: Zimmer Biomet.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Department of Orthopaedics University of North Carolina at Chapel Hill?

Department of Orthopaedics University of North Carolina at Chapel Hill has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Department of Orthopaedics University of North Carolina at Chapel Hill conducted?

Department of Orthopaedics University of North Carolina at Chapel Hill has 1 clinical trials on record, with 1 currently active. Their work covers Osteoarthritis, Avascular Necrosis of Bone of Hip, Post-traumatic; Arthrosis.

Is Department of Orthopaedics University of North Carolina at Chapel Hill accredited by Crixeo Health?

Department of Orthopaedics University of North Carolina at Chapel Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Department of Orthopaedics University of North Carolina at Chapel Hill?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.